Sotrovimab ensures 97% cure, zero fatality in COVID-19 cases, says UAE Ministry of Health
17 Jul 2021
Between June 30 and July 13, Sotrovimab was administered to 6,175 patients with COVID-19 in Abu Dhabi. About 52 per cent of the patients were aged 50 or above, and almost all recipients had multiple comorbidities including obesity, cancer, cardiovascular disease and diabetes.